Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 18;13(8):1634.
doi: 10.3390/v13081634.

Serological Screening for Antibodies against SARS-CoV-2 in Dutch Shelter Cats

Affiliations

Serological Screening for Antibodies against SARS-CoV-2 in Dutch Shelter Cats

W J R van der Leij et al. Viruses. .

Abstract

The COVID-19 pandemic raised concerns that companion animals might be infected with, and could become a reservoir of, SARS-CoV-2. As cats are popular pets and susceptible to Coronavirus, we investigated the seroprevalence of SARS-CoV-2 antibodies in shelter cats housed in Dutch animal shelters during the COVID-19 pandemic. In this large-scale cross-sectional study, serum samples of shelter cats were collected during the second wave of human COVID-19 infections in The Netherlands. Seroprevalence was determined by using an indirect protein-based ELISA validated for cats, and a Virus Neutralization Test (VNT) as confirmation. To screen for feline SARS-CoV-2 shedding, oropharyngeal and rectal swabs of cats positive for ELISA and/or VNT were analyzed using PCR tests. In 28 Dutch animal shelters, 240 shelter cats were convenience sampled. Two of these cats (0.8%; CI 95%: 0.1-3.0%) were seropositive, as evidenced by the presence of SARS-CoV-2 neutralizing antibodies. The seropositive animals tested PCR negative for SARS-CoV-2. Based on the results of this study, it is unlikely that shelter cats could be a reservoir of SARS-CoV-2 or pose a (significant) risk to public health.

Keywords: Coronavirus disease 2019 (COVID-19); animal shelter; neutralizing SARS-CoV-2 antibody; one health; serology; seroprevalence; shelter medicine; titer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; in the decision to publish the results.

Figures

Figure 1
Figure 1
Outline of Dutch municipalities (apricot color) served by the participating animal shelters in this study.

Similar articles

Cited by

References

    1. Bosco-Lauth A.M., Hartwig A.E., Porter S.M., Gordy P.W., Nehring M., Byas A.D., VandeWoude S., Ragan I.K., Maison R.M., Bowen R.A. Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats. Proc. Natl. Acad. Sci. USA. 2020;117:26382–26388. doi: 10.1073/pnas.2013102117. - DOI - PMC - PubMed
    1. Gaudreault N.N., Trujillo J.D., Carossino M., Meekins D.A., Morozov I., Madden D.W., Indran S.V., Bold D., Balaraman V., Kwon T., et al. SARS-CoV-2 infection, disease and transmission in domestic cats. Emerg. Microbes Infect. 2020;9:2322–2332. doi: 10.1080/22221751.2020.1833687. - DOI - PMC - PubMed
    1. Fritz M., Rosolen B., Krafft E., Becquart P., Elguero E., Vratskikh O., Denolly S., Boson B., Vanhomwegen J., Ar Gouilh M., et al. High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households. One Health. 2020;11:100192. doi: 10.1016/j.onehlt.2020.100192. - DOI - PMC - PubMed
    1. Zhang Q., Zhang H., Huang K., Yang Y., Hui X., Gao J., He X., Li C., Gong W., Zhang Y., et al. SARS-CoV-2 Neutralizing Serum Antibodies in Cats: A Serological Investigation. [(accessed on 30 March 2021)];bioRxiv. 2020 Available online: https://www.biorxiv.org/content/10.1101/2020.04.01.021196v1. - DOI
    1. World Organisation for Animal Health OIE. [(accessed on 12 June 2021)]; Available online: https://www.oie.int/en/what-we-offer/emergency-and-resilience/covid-19/

Publication types

MeSH terms